Start-ups

Intelomed

Intelomed is developing a non-contact patient-monitoring device to improve telehealth treatment outcomes. Using only the camera of a smartphone, mCVInsight (Mobile Cardiovascular Insight) will measure the micro-changes of color of a patient’s face in order to provide clinicians with valuable diagnostics and patient data in real-time. Intelomed is currently in-market with previous patient-monitoring technology and is actively working to secure FDA-clearance for mCVInsight. Intelomed's mCVInsight is currently in the prototype stages of development.

Explore this Opportunity!

Similar Opportunities

Offered by

With the StartEngine platform, users have the ability to invest in startups for as little as $100.

Asset Class:
Start-ups
Min Investment:
$
100
Target Return:
Varied
Fees:
0%
Established:
2015
Available to:
All Investors
Click Here To Learn More About this Platform!